 SOLANA BEACH, Calif., Nov. 03, 2021 GLOBE NEWSWIRE -- Evoke Pharma, Inc. Nasdaq: EVOK, a specialty pharmaceutical company focused on treatments for gastrointestinal GI disorders and diseases, today announced that the Company is scheduled to release its third quarter 2021 financial results on Wednesday, November 10, 2021, after the market closes. 